Weight Loss
GLP-1 medications start acting with the first dose, but weight loss builds over months. Here is what the research shows about the timeline, and why the early weeks can feel slow.
SailRx Editorial
Editorial Team
6 min read
GLP-1 medications such as semaglutide and tirzepatide begin acting in the body after the first injection, but weight loss is gradual. Appetite tends to change first, while the bigger shifts on the scale usually build over several months as the dose is slowly raised. In the large trials behind these medications, the main results were measured after roughly a year and a half of treatment.
That gap between "it's working" and "I can see it working" is where most of the questions come from. Here is what the research shows, step by step.
GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after you eat. It helps signal that you have had enough. GLP-1 medications are lab-made versions of this signal that last much longer than the natural hormone. Tirzepatide acts on a second hormone receptor as well, called GIP (glucose-dependent insulinotropic polypeptide), which is why it is described as a dual agonist.
The practical effect is on appetite. In a 12-week study of once-weekly semaglutide, participants ate about 35% fewer calories at a meal where they could eat as much as they liked. They also reported less hunger, fewer food cravings, and better control over how much they ate, compared with when they took a placebo.
Two things shape the early weeks: the dose and the way the medication builds up in your body.
In the major trials, nobody started on their final dose. Both the semaglutide and tirzepatide studies began with a low dose and raised it in steps every four weeks until participants reached their target. Starting low gives your digestive system time to adjust. The most common side effects in these trials were nausea and diarrhea, and in the semaglutide trial they were usually mild to moderate and eased over time.
The trade-off is that the first month or two are spent on doses below the ones studied for full effect. Slow early progress at this stage is expected, not a sign that the medication is failing.
Both medications stay in the body for a long time. Semaglutide has a half-life of about one week, meaning it takes about a week for the amount in your body to fall by half. Tirzepatide's half-life is about five days. Because each weekly dose arrives before the last one has cleared, levels build up over the first several weeks and then hold steady. For semaglutide, that steady level is reached after about four to five weeks at a given dose; for tirzepatide, after about four weeks.
Everyone responds differently, so think of this as what studies observed on average, not a schedule your body has to follow.
The medication is active, the dose is at its lowest, and levels are still building. Some people notice smaller portions feel like enough or that snacking loses some of its pull. Others notice little at all. Mild stomach side effects are most likely in this window and when the dose is increased.
As the dose steps up, effects on appetite and weight tend to become more noticeable. One trial gives a useful checkpoint: in the first 20 weeks of semaglutide treatment, while the dose was raised to its target, participants lost an average of about 10.6% of their body weight.
Weight loss continued well past the escalation period in both large trials:
These are averages across large groups. Individual results ranged widely in both directions. Both studies also paired the medication with a reduced-calorie diet and increased physical activity.
Because both medications have long half-lives, levels in your body stay relatively steady between weekly doses once they have built up. If you notice appetite returning before your next dose, raise it with your provider rather than adjusting the schedule on your own.
A slow start is common, and there are several ordinary reasons for it:
If several months pass with little change, that is a reason to review your plan with a provider. They may look at your dose, side effects, and habits together.
GLP-1 medications help while you take them. In one trial, people who had already lost weight on semaglutide for 20 weeks were split into two groups. Those who continued lost an additional 7.9% of their body weight over the next 48 weeks. Those who switched to a placebo regained 6.9%. For most people, these medications work best as a long-term part of a weight-management plan.
The trial results above come from studies of the FDA-approved medications. Compounded semaglutide and tirzepatide are prepared by pharmacies and are not FDA-approved, which means the FDA does not review them for safety, effectiveness, or quality before they are dispensed. They were not the products studied in these trials. That is why who prepares your medication and who oversees your care matter. At SailRx, every treatment plan is physician-guided from your first assessment through each dose change, and medications are prepared by FDA-registered pharmacies. You can read how our tirzepatide treatment plan works, including how dosing is adjusted over time.
The earliest signs are usually about appetite rather than weight: feeling satisfied with smaller portions, thinking about food less, or fewer cravings between meals. Weight changes tend to follow over the next several months as the dose increases.
Maybe, maybe not, and either is normal. The first dose is the lowest, and the medication takes several weeks to build to a steady level, so most changes arrive gradually rather than overnight.
Raising the dose gradually gives your digestive system time to adjust and lowers the chance of stronger side effects. Your provider decides when and whether to increase it based on how you are feeling.
Both follow a similar pattern of gradual dose increases, and both build up over several weeks. In separate trials, average weight loss at the end of treatment was higher with tirzepatide, but the studies were not head-to-head and individual responses vary. A provider can help you weigh the options for your health history.
GLP-1 medications start working right away, but meaningful change is measured in months, not days. If you are wondering whether this kind of treatment is right for you, the next step is a conversation with a licensed provider who can review your health history and goals.
Written by
SailRx Editorial
Editorial Team
The SailRx team writes about weight loss and longevity treatment using peer-reviewed research.
This article is for general educational purposes only and is not medical advice. It does not replace a consultation with a licensed healthcare provider, who will determine whether any treatment is appropriate for you. Compounded medications are not FDA-approved. How we write our articles.